Skip to content

Canadian Pharmacy Regulatory Authorities:

AB
BC
MB
NB
NL
NS
NT
NU
ON
PE
QC
SK
YT
All

Search for:

National Drug Schedules Program
Resources
International
News

National Drug Schedules Program
Resources
International
News
Login
NAPRA Groups

Avapritinib or its salts

Avapritinib or its salts

Approval Date: December 20, 2024

Schedule: I

Footnote: PDL

About NAPRA|

Canadian Pharmacy Regulatory Authorities:

AB
BC
MB
NB
NL
NS
NT
NU
ON
PE
QC
SK
YT
All

Contact

Mailing Address:
M615–1554 Carling Avenue
Ottawa, Ontario K1Z 7M4 Canada

Phone: 1 (613) 569-9658
info@napra.ca

Subscribe to Updates from NAPRA

Receive NAPRA updates of interest directly to your inbox: general NAPRA news, NDS updates and/or updates on practice resources.

SUBSCRIBE NOW

2025 © Copyright National Association of Pharmacy Regulatory Authorities. All Rights Reserved. Privacy Policy